T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
2020 · Nature Medicine · 167 citations
https://doi.org/10.1038/s41591-020-0858-8
J
John P. Vasilakos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
6.5K
Citations
35
h-index
47
i10-index
John P. Vasilakos is an academic researcher from Kindeva Drug Delivery (United States). The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Response and Inflammation & Immune Cell Function and Interaction. The author has an h-index of 35, co-authored 60 publications.
ORCID: 0000-0002-1075-9665Papers by this author
worksComparison of human B cell activation by TLR7 and TLR9 agonists
2008 · BMC Immunology · 122 citations
https://doi.org/10.1186/1471-2172-9-39
Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells
1993 · The Journal of Immunology · 42 citations
https://doi.org/10.4049/jimmunol.150.6.2346
IL-1 β converting enzyme (ICE) is not required for apoptosis induced by lymphokine deprivation in an IL-2-dependent T cell line
1995 · The Journal of Immunology · 32 citations
https://doi.org/10.4049/jimmunol.155.7.3433
Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination
2015 · Journal of Biological Chemistry · 18 citations
https://doi.org/10.1074/jbc.m115.701151
Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques
2023 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-023-40430-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat